摘要
目的 观察螺旋藻加转移因子辅助治疗复治肺结核疗效。方法 将 1 92例涂阳复治患者随机分为治疗组 (1 0 0例 )和对照组 (92例 )。 2组化疗方案相同 ,治疗组在化疗同时加螺旋藻胶囊 3粒口服 ,3次 /d ;转移因子 3mg ,皮下注射 ,2次 /周。结果 9月末痰菌阴转率 ,治疗组 92 %,对照组73.9%(P <0 .0 1 ) ;X线胸片病灶吸收好转率和空洞闭合率治疗组分别为 88%和 76 %,对照组分别为 73.9%和 5 9.8%(P <0 .0 5 )。治疗组不良反应发生率明显低于对照组 (分别为 6 %和 2 6 %,P <0 .0 1 )。结论 两药联合辅助治疗复治肺结核有效 ,并可降低抗结核药物不良反应的发生率。
Objective To observe the supplementary treatment effect for pulmonary tuberculosis treated of spirin and transfer factor.Methods One hundred and ninety two patients were divided into two groups: therapy group with 100 cases, control group with 92 cases. The therapy group received chemical therapy and three spirin capsules, three times a day, transfer factor 3mg, imjection(H) twice a week.Results At the end of 9 months, the sputum conversion rate was 92%(in therapy group), 73.9%(in control group), P<0.01. The foci absorption was 88%(therapy group) and 76%(control group), Cavity cloce up was 73.9% (ther-apy group), 59.8%(control group),P<0.05. The therapy group's side effect rate (6%) was lower than that of control group(26%), P<0.01. Conclusion The supplementary treatment effect of spirin and transfer factor for treating retreated pulmonary tuberculosis was obvious. Especially for reducing side effect of antituberculosis.
出处
《中国防痨杂志》
CAS
2005年第1期33-35,共3页
Chinese Journal of Antituberculosis
